Mtap Deleted Solid Tumors Clinical Trials

ReadTheTrial indexes 1 studies for Mtap Deleted Solid Tumors. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Mtap Deleted Solid Tumors.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials for Mtap Deleted Solid Tumors

A Phase 1/2, Open-label, Multicenter Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Antineoplastic Activity of S095035 (MAT2A Inhibitor) as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Homozygous Deletion of MTAP

NCT06188702 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Mtap Deleted Solid Tumors?

There are 1 clinical trials listed for Mtap Deleted Solid Tumors. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Mtap Deleted Solid Tumors trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Mtap Deleted Solid Tumors trials in?

Current Mtap Deleted Solid Tumors trials are distributed across: Phase 2 (1).

Find More Trials